Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amrubicin Receives FDA Fast Track Designation For The Treatment Of Small Cell Lung Cancer After First-Line Chemotherapy
Amrubicin Receives FDA Fast Track Designation For The Treatment Of Small Cell Lung Cancer After First-Line Chemotherapy
Amrubicin Receives FDA Fast Track Designation For The Treatment Of Small Cell Lung Cancer After First-Line Chemotherapy
Submitted by
admin
on September 6, 2008 - 10:33am
Source:
Medical News Today
Headline:
Amrubicin Receives FDA Fast Track Designation For The Treatment Of Small Cell Lung Cancer After First-Line Chemotherapy
Do Not Allow Advertisers to Use My Personal information
